First human trial of AstraZeneca COVID-19 vaccine shows promise

First human trial of AstraZeneca COVID-19 vaccine shows promise

According to trial results published in The Lancet medical journal, AstraZeneca’s experimental COVID-19 vaccine, AZD1222 was found safe and produced an immune response in early-stage clinical trials in healthy volunteers. However, more research is needed before one can confirm the vaccine effectively protects against Covid-19 infection, and for how long the protection of the vaccine lasts.

Milan
Milan
Top in World
Get the App